Advisory Research’s Kyntra Bio KYNB Stock Holding History

Advisory Research’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-813	Closed	-$1.1M	–	375
2019 Q1	$1.1M	Sell	813 -222	-21%	-$301K	0.02%	235
2018 Q4	$1.2M	Buy	1,035 +130	+14%	+$146K	0.03%	219
2018 Q3	$1.38M	Buy	+905	New	+$1.39M	0.02%	234
2017 Q4	–	Sell	-959	Closed	-$1.29M	–	417
2017 Q3	$1.29M	Sell	959 -355	-27%	-$374K	0.02%	270
2017 Q2	$1.06M	Buy	+1,314	New	+$915K	0.02%	313

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Advisory Research's KYNB Position: Q2 2019 in Review

Advisory Research sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 813 shares — an estimated $1.1M sold.

Advisory Research first reported a position in KYNB in Q2 2017 and held it in 5 quarters. The position peaked at $1.38M in Q3 2018. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

Advisory Research reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
Advisory Research sold 813 Kyntra Bio shares in Q2 2019, an estimated $1.1M.
Advisory Research first reported a position in Kyntra Bio in Q2 2017 and held it in 5 quarters.
Advisory Research's Kyntra Bio position peaked at $1.38M in Q3 2018.
190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Advisory Research's 13F filing for Q2 2019, filed 14 Aug 2019.